Silver-hollow mesoporous silica nanoparticles for clarithromycin delivery in an animal model of helicobacter pylori

Silver-hollow mesoporous silica nanoparticles for clarithromycin delivery in an animal model of helicobacter pylori

Background: Nanoparticle-based drug delivery systems offer a promising approach to overcoming antimicrobial resistance and enhancing therapeutic efficacy.Objective(s): This study aimed to evaluate the efficacy of silver-hollow mesoporous silica nanoparticles (Ag-HMSNs) in the targeted delivery of cl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Soroush Mirfakhraee, Reza Mirnejad, Maryam Iman
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2025-07-01
Series:	Nanomedicine Journal
Subjects:	drug liberation drug delivery systems helicobacter pylori mesoporous silica nanoparticles
Online Access:	https://nmj.mums.ac.ir/article_26056_cde7f30fd34429223518d64bc4124385.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clarithromycin Resistance Rates of Helicobacter pylori Infected Gastric Biopsies in Korea
by: Moo-Sang CHONG, et al.
Published: (2025-06-01)

Optimal First-line Eradication Regimens for Helicobacter pylori Infection in Patients with Clarithromycin Resistance: A Pilot Study
by: Min Woo Seo, et al.
Published: (2018-12-01)

Status of Helicobacter pylori Eradication in Japan
by: Gwang Ha Kim
Published: (2017-03-01)

Detection of Clarithromycin Resistance in Helicobacter pylori Using the AllplexTM H. pylori & ClariR Assay and the Ezplex® HP-CLA Real-Time PCR Kit
by: Tae-Woo Kim, et al.
Published: (2025-03-01)

Application research of hollow mesoporous silica nanoparticles in targeted thrombolysis for deep vein thrombosis of the lower extremities
by: Shasha He, et al.
Published: (2025-03-01)

Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
by: Hafeza Aftab, et al.
Published: (2016-03-01)

Antimicrobial Resistance of Helicobacter pylori Isolates in Korea
by: Eun Jeong Gong, et al.
Published: (2018-06-01)

Recent advances in mesoporous silica nanoparticle: synthesis, drug loading, release mechanisms, and diverse applications
by: Rabia Fatima, et al.
Published: (2025-03-01)

Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients
by: Guilherme Felga, et al.
Published: (2010-07-01)

Comparing Two Treatment Regimens for Helicobacter pylori Eradication: Furazolidone or Clarithromycin?
by: Shirin Rezaei, et al.
Published: (2025-07-01)

Functionalized Mesoporous Silica Nanoparticles as a Novel Antioxidant Delivery System
Published: (2015-10-01)

Controlled release of dexamethasone phosphate from modified mesoporous biocompatible silica nanoparticles: synthesis, characterization, and kinetic studies
by: Juan Manuel Galdopórpora, et al.
Published: (2025-02-01)

Disordered mesoporous silica particles: an emerging platform to deliver proteins to the lungs
by: Aura Rocío Hernández, et al.
Published: (2024-12-01)

Targeted nanomedicines for the treatment of Helicobacter pylori infection
by: Shi Wang, et al.
Published: (2025-06-01)

A Pilot Study of Helicobacter pylori Eradication Using a Polymerase Chain Reaction-based Test for Clarithromycin Resistance
by: Yun Duk Jung, et al.
Published: (2017-12-01)

Molecular detection of clarithromycin-resistant Helicobacter pylori in stool samples using real-time PCR
by: Menna allah Mohamed, et al.
Published: (2025-08-01)

Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children
by: Yeliz Çağan-Appak, et al.
Published: (2016-08-01)

Design and fabrication of a mesoporous silica scaffold for oral delivery of peptides
by: Yasir Mehmood, et al.
Published: (2025-08-01)

Clinical and Pharmacological Aspects of Resistance to Eradication Therapy of Helicobacter Pylori Infection
by: S. Yu. Serebrova, et al.
Published: (2020-05-01)

Analysis of the status and risk factors for Helicobacter pylori infection and drug resistance in the Lianyungang area, China
by: Chuchu Yang, et al.
Published: (2025-02-01)

Application of Ordered Porous Silica Materials in Drug Delivery: A Review
by: Wenwen Liu, et al.
Published: (2024-12-01)

Impregnation of non-steroidal anti-inflammatory drugs (ibuprofen and ketoprofen) onto mesoporous silica SBA-15 using supercritical CO2
by: Kairi Yamamoto, et al.
Published: (2025-02-01)

Biological Cost of Helicobacter pylori Rifampicin Resistance
by: K. T. Momynaliev, et al.
Published: (2020-05-01)

An update of laboratory diagnosis of Helicobacter pylori in the Kingdom of Saudi Arabia
by: Ali M Somily, et al.
Published: (2015-08-01)

Kinetic and Methodological Insights into Hydrophilic Drug Release from Mesoporous Silica Nanocarriers
by: Rodrigo Rozas, et al.
Published: (2025-05-01)

New Approaches to Therapy of Helicobacter pylori Infection (by the Materials of the Maastricht Consensus-IV, Florence, 2010)
by: A. G. Evdokimova, et al.
Published: (2020-05-01)

Prospective Multicenter Surveillance of Non–H. pylori Helicobacter Infections during Medical Checkups, Japan
by: Kengo Tokunaga, et al.
Published: (2025-06-01)

Potential Unnecessity of Bismuth in Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori Infection
by: Seon Woo Oh, et al.
Published: (2025-03-01)

Eradication Therapy for Pediatric Helicobacter pylori Infection
by: Ji-Hyun Seo, et al.
Published: (2017-03-01)

The Usefulness of Serology in the Diagnosis of Helicobacter Pylori Infection
by: Mahmood Al-Mendalawi
Published: (2023-06-01)

Clinical evaluation of personalized Helicobacter pylori treatment guided by PCR detection from fecal samples: a real-world study
by: Ruolin Peng, et al.
Published: (2025-04-01)

Multifractal Analysis and Experimental Evaluation of MCM-48 Mesoporous Silica as a Drug Delivery System for Metformin Hydrochloride
by: Mousa Sha’at, et al.
Published: (2024-12-01)

Clarithromycin-resistant Helicobacter pylori in Africa: a systematic review and meta-analysis
by: Komla Mawunyo Dossouvi, et al.
Published: (2025-04-01)

Sustainable Pest Management with Hollow Mesoporous Silica Nanoparticles Loaded with β-Cypermethrin
by: Min Li, et al.
Published: (2025-03-01)

Current prevalence of Helicobacter pylori infection in patients with dyspepsia treated in Warsaw, Poland
by: Tadeusz Tacikowski, et al.
Published: (2017-05-01)

Drug delivery systems based on mesoporous silica nanoparticles for the management of hepatic diseases
by: Boyan Liu, et al.
Published: (2025-02-01)

Chlorotoxin-functionalized mesoporous silica nanoparticles for pH-responsive paclitaxel delivery to Glioblastoma multiforme
by: Mirjana Mundžić, et al.
Published: (2025-01-01)

The Application of Mesoporous Silica Nanoparticles in Enhancing the Efficacy of Anti-Atherosclerosis Therapies: A Review
by: Budiman A, et al.
Published: (2025-08-01)

Characterization of Helicobacter Pylori Infection in Patients with Gastric Ulcer
by: Marcos Félix Osorio Pagola, et al.
Published: (2009-12-01)

The effect of mesoporous silica doped with silver nanoparticles on glass ionomer cements; physiochemical, mechanical and ion release analysis
by: Syed Saad Bin Qasim, et al.
Published: (2024-10-01)